MEA In-vitro Diagnostics Market Share, Revenue, Trends, Scope, CAGR Status, Business Challenges and Growth Opportunities Till 2033


MEA In-vitro Diagnostics Market Share, Revenue, Trends, Scope, CAGR Status, Business Challenges and Growth Opportunities Till 2033: SPER Market Research

 Category : Healthcare

 Published: Jan-2024
 Author: SPER Analyst

Middle East and Africa In-vitro Diagnostics Market is projected to be worth USD 7.07 billion by 2033 and is anticipated to surge at a CAGR of 5.76%.  

As opposed to in vivo testing, which are conducted within the body, in-vitro tests are typically conducted in test tubes and related equipment. The term "in glass" refers to this. Precision medicine may also use in-vitro diagnostics to identify patients who may benefit from specific medications or treatments. These in-vitro diagnostic procedures might use next-generation sequencing tests, which look for genetic changes in a person's DNA. While certain tests can be performed by patients at home, others are performed in laboratories or other venues involving health professionals. 

Middle East and Africa In-vitro Diagnostics Market Driving Factors and Challenges
The clinical laboratory market has advanced significantly as a result of the introduction of new technologies and the expanding presence of independent, commercial laboratories. As a result of technological breakthroughs, there has been a noticeable shift away from hospital-based laboratories and toward independent labs. Significant increase is anticipated in the fields of point of care testing (POCT) and in-vitro diagnostics (IVD). For the diagnosis of infectious diseases, there has been a noticeable increase in the demand for quick, affordable, and user-friendly POCT instruments. Smart labs-as-a-service, which automate laboratory activities, the need for next-generation sequencing testing for genetic testing, and the adoption of managed clinical services are other key sectors with substantial growth potential.

It may be difficult to reimburse in-vitro diagnostics instruments due to the complicated regulatory landscape in the Middle East and Africa. Furthermore, a lack of capital-intensive equipment in the region's healthcare facilities limits the use and uptake of cutting-edge technologies. One report from the Southern African Research & Innovation Management Association, for example, claims that South Africa has a limited medical device business, and that neither the patient nor the physician is aware of the device's cost. Incentives that could lower the device's cost are also absent. Hence, it is projected that a lack of knowledge regarding reimbursement programs will restrict market expansion.

Impact of COVID-19 on Middle East and Africa In-vitro Diagnostics Market 
Due to the rising need for IVD kits and reagents for the quick and precise diagnosis of SARS-CoV-2 virus infection in the local population, the COVID-19 pandemic had a substantial effect on the in-vitro diagnostics market. According to the UN report from 2022, the WHO was able to increase the number of laboratories that were able to detect COVID-19 from two to over 900 with the aid of various initiatives, such as the creation of the Regional Centre of Excellence for Genomic Surveillance and Bioinformatics in South Africa in partnership with the SANBI at the University of Western Cape. Moreover, WHO backed African attempts in genetic sequencing . The government's initiatives and associated resources encouraged the in-vitro diagnostics market to flourish in the area under study.

Middle East and Africa In-vitro Diagnostics Market Key Players
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as major key players are Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, BioMerieux SA, Siemens Healthineers, Thermo Fischer Scientific Inc., Seegene Inc., Sysmex Corporation and various others.

Middle East and Africa In-vitro Diagnostics Market Segmentation:

By Product and Service: Based on the Product and Service, Middle East and Africa In-vitro Diagnostics Market is segmented as; Instruments, Reagents and Kits, Software and Services.

By Technology: Based on the Technology, Middle East and Africa In-vitro Diagnostics Market is segmented as; Blood Glucose Self-Monitoring, Clinical Chemistry, Coagulation and Haemostasis, Haematology, Immunoassay/Immunochemistry, Microbiology, Molecular Diagnostics, Urinalysis, Others.

By Application: Based on the Application, Middle East and Africa In-vitro Diagnostics Market is segmented as; Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, Nephrology, Oncology, Others.

By Region: This research also includes data for GCC5, South Africa, and Rest of Middle East & Africa.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]